Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
0.9989
+0.0039 (0.39%)
At close: Jun 27, 2025, 4:00 PM
0.9999
+0.0010 (0.10%)
After-hours: Jun 27, 2025, 5:15 PM EDT
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $30.06 million as of June 27, 2025. Its market cap has decreased by -53.90% in one year.
Market Cap
30.06M
Enterprise Value
27.77M
1-Year Change
-53.90%
Ranking
Category
Stock Price
$1.00
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $30.06M, a decrease of -68.29%. That is a compound annual growth rate of -16.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 30.10M | -41.89% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |